What is the role of glimepiride in inhibiting SARS-CoV-2?
Label:chem
Topic
Glimepiride is an anti-diabetic drug that has been suggested to potentially target SARS-CoV-2 Mpro, a viral protease crucial for polyprotein processing. This study evaluates its ability to inhibit SARS-CoV-2 by targeting the ACE2 receptor.
From: "Drug repurposing of argatroban, glimepiride and ranolazine shows anti-SARS-CoV-2 activity via diverse mechanisms", Heliyon, Volume 11, Issue 3, 15 February 2025, e41894
Answer
Glimepiride inhibits SARS-CoV-2 primarily by inhibiting intracellular viral replication and to a lesser extent by inhibiting viral adsorption. It has an IC50 of 47 μM and a CC50 of 2860 μM, with a selectivity index of 61, indicating its relative safety and potential as a therapeutic agent.
Return to Home
Chemical List
Knowledge you may be interested in